Includes Lyme disease and other tick-borne diseases as occupational diseases for purposes of workers' compensation; clarifies that disability includes disability caused by Lyme disease or other tick-borne diseases; requires insurance coverage of long term medical care for Lyme disease and other tick borne diseases.
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
Enacts the "public university emergency contraception education act" requiring public universities to develop, produce and distribute informational materials related to emergency contraception.
This bill creates a certification process for organizations providing in-home substance use disorder treatment services in New York. It requires applicants (including out-of-state entities registered with the state) to meet specific clinical standards, including conducting screenings for overdose risk, mental health conditions, and suicide risk. Certified providers must implement safety plans, medication-assisted treatment, naloxone access, and regular recovery planning. The law aims to standardize and expand access to in-home treatment while ensuring providers meet defined safety and clinical requirements.
Establishes an intensive addiction and medical services integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and medical services integrated services to individuals who have significant addiction and medical issues.
Ensures that public retirees are not having their skilled nursing care benefits reduced under the state health benefit plan at the time they enroll for medicare.
Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.
Directs the department of health to establish an alternative payment methodology (APM) for federally qualified health centers to preserve and improve patient access to fertility care.
This bill (S 3155) requires health insurers to provide in vitro fertilization (IVF) coverage without discrimination. It prohibits insurers from denying or limiting IVF coverage based on factors like age, disability, sexual orientation, gender identity, or perceived quality of life. The bill specifically bans insurers from requiring all embryos from a previous IVF cycle to be transferred before covering a subsequent cycle for women aged 35 or older. These changes directly affect individuals seeking IVF treatment by expanding access and preventing discriminatory practices in insurance coverage.
This bill allows New York pharmacists to administer FDA-approved progestin-only contraceptive injections, expanding access to this specific form of birth control. It requires pharmacists to complete training, provide patient screening questionnaires and fact sheets about clinical considerations, and notify a patient's primary care provider (unless the patient opts out). The policy directly affects patients seeking contraception and pharmacists who will administer the injections. Key safety mechanisms include mandatory screenings, provider notifications, and pharmacist discretion to refuse service if health risks are identified.
